Dytor
Dytor is Cipla’s torasemide 5/10/20 mg tablets — long-acting loop diuretic with 80-100% predictable bioavailability (vs furosemide 10-90%). Preferred in patients with gut oedema, inconsistent furosemide response, or needing once-daily loop coverage. Mild aldosterone antagonism reduces hypokalaemia. Only loop diuretic with reasonable hypertension evidence. TRANSFORM-HF 2023 — equivalent mortality to furosemide in heart failure.
✓ Medisch beoordeeld door Morgan Ellis — Apotheekonderzoeker · 8 jaar ervaring · Laatst beoordeeld: mei 2026
⚡ Quick Answer — What is Dytor?
Dytor is een 5 / 10 / 20 mg torasemide tablet from Cipla — a loop diuretic (pyridine-sulfonylurea structure) that acts on the NKCC2 (Na-K-2Cl cotransporter) in the thick ascending limb. Torasemide (torsemide in US nomenclature) was introduced by Boehringer Mannheim in 1993 — the third major loop diuretic after furosemide and bumetanide. Marketed on its predictable bioavailability and longer duration vs furosemide. Half-life 3-4 hours (longer than furosemide); onset 30-60 minutes; peak effect 1-2 hours; duration 6-8 hours. Primary indication: chronic heart-failure oedema, hypertension (including refractory), hepatic ascites, oedema of chronic kidney disease. Typical dosing: Hypertension: 5-10 mg once daily in the morning. Torasemide is the only loop diuretic with reasonable antihypertensive evidence — its longer effect duration and additional anti-aldosterone/anti-fibrotic activity make it better suited for once-daily BP control than furosemide. Key contraindications: see full list below. Monitor electrolytes, creatinine, and glucose. Do not combine with lithium (thiazide/loop diuretics can precipitate lithium toxicity). Pregnancy use is case-specific (see pregnancy note). For most hypertensive patients, diuretics work best as the second or third agent — typically combined with an ARB, ACE inhibitor, or calcium-channel blocker rather than used alone.
📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.
Waarom bestellen bij MedsBase
Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.
What Is Dytor?
Dytor is an oral 5 / 10 / 20 mg torasemide tablet from Cipla, supplied in 30-180 tablets. Torasemide (torsemide in US nomenclature) was introduced by Boehringer Mannheim in 1993 — the third major loop diuretic after furosemide and bumetanide. Marketed on its predictable bioavailability and longer duration vs furosemide.
How Torasemide Works
Torasemide inhibits the NKCC2 (Na-K-2Cl cotransporter) in the thick ascending limb. The downstream effects:
- Dramatic reduction in sodium reabsorption — loop diuretics block the largest sodium-reabsorbing segment of the nephron; up to 25% of filtered sodium can be excreted
- Large diuresis within 1-2 hours of oral dosing (5 minutes IV) — useful for acute decompensated heart failure and pulmonary oedema
- Loss of magnesium and calcium in addition to sodium and potassium — contrasts with thiazides which retain calcium
- Direct venodilation within minutes of IV dosing — contributes to symptom relief in acute pulmonary oedema before the diuresis arrives
- Activates prostaglandin synthesis in the kidney — the basis of the NSAID interaction (NSAIDs blunt loop diuretic effect)
- Mild mineralocorticoid receptor antagonism — reduces hypokalaemia and provides partial anti-fibrotic activity on myocardium
Approved and Evidence-Based Uses
- Chronic heart-failure oedema, hypertension (including refractory), hepatic ascites, oedema of chronic kidney disease — primary indication
- Chronic heart failure with oedema
- Cirrhotic ascites (combined with spironolactone)
- Hypertension, including refractory hypertension (only loop diuretic with reasonable HTN evidence)
- CKD-related oedema — effective at eGFR <30 where thiazides fail
- Furosemide non-response — switching to torasemide often restores response due to better bioavailability
Pivotal trial evidence: TORIC trial (2002) — observational study of 1,377 HF patients; torasemide vs furosemide, torasemide arm showed 52% lower mortality. Widely cited but criticised for non-randomised design. TRANSFORM-HF (2023) — large randomised trial of 2,859 HF patients, torasemide vs furosemide; no significant difference in all-cause mortality at 12 months. Current verdict: torasemide is at least as good as furosemide; the choice turns on bioavailability, convenience, and tolerability rather than mortality.
Dytor Dosage
Chronic dose: Hypertension: 5-10 mg once daily in the morning. Torasemide is the only loop diuretic with reasonable antihypertensive evidence — its longer effect duration and additional anti-aldosterone/anti-fibrotic activity make it better suited for once-daily BP control than furosemide.
Other indications: Heart failure: 10-20 mg PO daily initially; titrate to 10-100 mg/day. Once-daily dosing is typically adequate. Cirrhotic ascites: 5-40 mg/day in combination with spironolactone 100-200 mg/day. CKD oedema: higher doses required (20-100 mg/day) as nephrons drop.
Administration: once daily (or twice daily for high-dose loop diuretics in HF), in the morning. Evening dosing causes nocturia and should be avoided when possible. Take at the same time each day. Food does not significantly affect absorption for any of these diuretics.
Monitoring schedule:
- Baseline: urea, electrolytes (especially potassium and sodium), creatinine, eGFR, glucose, serum urate. Home or clinic BP and daily weight for HF patients.
- 1-2 weeks after start or dose change: repeat U&E and creatinine. Expect mild electrolyte shifts; investigate substantial changes.
- 4-6 weeks: BP review and full metabolic panel.
- Ongoing: annual U&E, urate, glucose, and lipid panel once stable. More frequent in CKD, HF, or on combination therapy.
- Stop or dose-reduce on: sodium <130 with symptoms, potassium <3.0 or >5.5, creatinine rise >30%, new gout, severe dehydration symptoms.
Discontinuation: no withdrawal syndrome but abrupt stop can cause rebound volume retention in HF patients on chronic high-dose loop diuretics — taper where possible and monitor weight.
- Bioavailability 80-100% (furosemide 10-90%) — particularly useful in patients with congested heart failure, gut oedema, or inconsistent response to furosemide.
- Mild aldosterone antagonism — partial anti-fibrotic activity in myocardium. Clinical significance modest; probably contributes to why TORIC showed benefit.
- Less hypokalaemic than furosemide at equivalent natriuretic doses (related to the aldosterone-antagonist effect).
- Equivalence dosing: torasemide 10 mg ≈ furosemide 40 mg. Useful when switching patients between agents.
Bijwerkingen
Common (>1%):
- Hypokalaemia (less than furosemide)
- Hypomagnesaemia
- Hyponatraemia
- Pre-renal AKI in over-diuresis
- Ototoxicity (rare; less than furosemide per unit of natriuresis)
- Hyperurikemie
- Mild hyperglycaemia
- Postural hypotension
- Dizziness, headache
Uncommon but clinically important:
- Severe hyponatraemia — particularly in elderly on low-salt diets, SIADH-prone states, or combined with SSRIs. Can present as confusion, falls, or seizures.
- Pancreatitis — rare thiazide/loop class effect; stop immediately on upper abdominal pain with lipase rise
- Thrombocytopenia, leucopenia, agranulocytosis — rare hypersensitivity reactions (more common with thiazides than loop agents)
- Acute myopia and angle-closure glaucoma — rare sulfonamide-class reaction within hours to days of starting; stop immediately if sudden painful eye or vision change
- Stevens-Johnson syndrome / toxic epidermal necrolysis — extremely rare but reported
Contra-indicaties
- Anuria
- Sulfonamide hypersensitivity
- Severe hepatic failure with hepatic coma
- Severe hyponatraemia or hypokalaemia at baseline
- Severe dehydration and pre-renal azotaemia
Pregnancy: avoided for routine hypertension; use only for clear indications (pulmonary oedema, resistant HF) under specialist care. Loop diuretics cross the placenta and can reduce fetal urine output.
Breastfeeding: generally acceptable at low doses; high doses can suppress lactation (particularly thiazides). Alternative antihypertensives (propranolol, nifedipine) preferred when possible.
Geneesmiddelinteracties
- Lithium — CRITICAL INTERACTION. Thiazide and loop diuretics reduce lithium renal clearance and can precipitate lithium toxicity. Avoid combination if possible; if unavoidable, monitor lithium levels weekly for the first month and reduce lithium dose by 25-50%.
- NSAID's — reduce diuretic effect (via prostaglandin blockade) and substantially raise AKI risk when combined with ACEi/ARB (the “triple whammy”). Use paracetamol preferentially for chronic pain.
- ACE inhibitors and ARBs — the combination is standard and beneficial in HTN; ACEi/ARB addition blocks compensatory RAAS activation and potentiates the diuretic effect. Monitor potassium and creatinine.
- Potassium supplements and potassium-sparing diuretics — often needed to offset loop/thiazide-induced hypokalaemia. Monitor potassium; avoid over-correction.
- Digoxine — hypokalaemia potentiates digoxin toxicity (loop and thiazide diuretics); spironolactone reduces digoxin clearance directly. Monitor digoxin levels and potassium when starting or changing diuretic.
- Oral corticosteroids, amphotericin B, stimulant laxatives — additive hypokalaemia (loop/thiazide) or masked potassium need (spironolactone).
- Oral antidiabetic drugs, insulin — thiazides and (less so) loops worsen glucose tolerance; may require dose adjustment.
- Cholestyramine / colestipol — reduce absorption of thiazides and loop diuretics by 40-85%. Separate dosing by 4 hours.
- Aminoglycoside antibiotics (gentamicin, amikacin) — additive ototoxicity. Avoid concurrent use at high IV doses.
- Alcohol — additive postural hypotension.
Where Dytor Fits in the Diuretic Class
| Klasse | Representatives | Typical use |
|---|---|---|
| Thiazide | HCTZ, chlorthalidone | HTN first-line, Ca stones, nephrogenic DI |
| Thiazide-like | Indapamide, metolazone | HTN (elderly, HYVET evidence), sequential nephron blockade |
| Loop (short) | Furosemide, bumetanide | Acute pulmonary oedema, CHF, ascites, hypercalcaemia |
| Loop (long) | Torasemide | Chronic CHF, HTN (only loop with HTN evidence), CKD oedema |
| Aldosterone antagonist | Spironolactone, eplerenone | HF-REF (RALES), resistant HTN (PATHWAY-2), Conn’s, cirrhotic ascites |
| Other K-sparing | Amiloride, triamterene (usually in combinations) | Prevention of hypokalaemia when added to loop/thiazide |
| Carbonic anhydrase | Acetazolamide | Altitude sickness, glaucoma, metabolic alkalosis |
Opslag
Store Dytor below 25°C in the original blister pack. Keep out of reach of children.
Veelgestelde vragen
When should I take Dytor — morning or evening?
Morning in almost all cases. The diuretic effect produces increased urine output for 2-4 hours after dosing. Evening dosing causes nocturia and disrupts sleep. Patients on twice-daily loop diuretics typically dose at breakfast and early afternoon (not bedtime).
Is Dytor a first-line blood-pressure drug?
Nee. Loop diuretics are not first-line antihypertensives — they are too short-acting and produce BP swings. Loop diuretics are used for hypertension only in specific situations: concurrent heart-failure oedema, advanced CKD (eGFR <30) where thiazides fail, or resistant hypertension as an add-on. For standard hypertension, choose a thiazide, ARB, ACE inhibitor, or calcium-channel blocker instead.
Will Dytor affect my potassium?
Yes — Dytor lowers potassium by increasing distal-tubule potassium excretion. Monitor at baseline, 1-2 weeks, and periodically. Hypokalaemia risk is minimised by combining Dytor with an ARB or ACE inhibitor — which is the standard combination in hypertension anyway. If potassium drops below 3.5 in isolated diuretic use, add potassium supplementation, a potassium-rich diet, or a small dose of a potassium-sparing agent (spironolactone, eplerenone, or an amiloride-containing combination).
I have gout — can I take Dytor?
With caution. Thiazides and (less so) loop diuretics raise serum uric acid by competing for proximal-tubule excretion. In gout-prone patients: prefer losartan-based combinations (Cosart H, Cozartan H) whose losartan component is uniquely uricosuric and offsets the thiazide urate rise. If Dytor is already in use and gout flares, add or continue urate-lowering therapy (allopurinol) rather than stopping Dytor outright.
I’m diabetic — is Dytor safe?
Mostly yes, but be aware that thiazides and (to a lesser extent) loop diuretics modestly worsen glucose tolerance (average fasting glucose rise 5-8 mg/dL, HbA1c 0.1-0.3%). The BP benefit outweighs this in most diabetics. If you want a more metabolically neutral combination, ARB+CCB is an alternative (Olmezest AM).
Can I take ibuprofen with Dytor?
Occasional short-term use is usually fine. Chronic daily NSAIDs (ibuprofen, diclofenac, naproxen) reduce the diuretic and antihypertensive effect of Dytor (prostaglandin blockade) and substantially raise the AKI risk when combined with an ACE inhibitor or ARB — the “triple whammy.” Use paracetamol preferentially for chronic pain.
Will I urinate more at night?
Usually no, if you take Dytor in the morning. The diuretic effect peaks 2-4 hours after dosing and has mostly worn off by evening. Nocturia is a common complaint when patients switch to evening dosing; switch back to morning dosing and nocturia resolves within 1-3 days.
Can I take Dytor in pregnancy?
Routinely avoided. Loop diuretics cross the placenta and can affect the fetus. For hypertension in pregnancy, switch to labetalol, methyldopa, or nifedipine. Diuretics are used in pregnancy only for specific indications (pulmonary oedema, resistant HF) under specialist supervision.
Wat als ik een dosis vergeet?
Take it as soon as you remember, unless it is nearly time for your next dose — in that case skip the missed dose. Do not double up. A single missed dose does not meaningfully affect long-term BP or fluid control.
Where can I buy Dytor online?
You can buy Dytor (5 / 10 / 20 mg torasemide, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.
Related Antihypertensives & Diuretics on MedsBase
- Amifru — Furosemide + Amiloride (loop + K-sparing)
- Cosart H — Losartan + HCTZ fixed combination
- Losar — Losartan (ARB partner for diuretic)
- Natrilix SR — Indapamide 1.5 mg SR (thiazide-like)
- Ramcor — Ramipril (ACEi partner for diuretic)
- Telmaheal — Telmisartan (ARB partner for diuretic)
- Browse all High Blood Pressure Medications
Gerelateerde alternatieven
Andere producten in Chronische aandoeningen die klanten ook bekijken:
Meer opties in medicatie tegen hoge bloeddruk
Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.
| Sterkte | 100 mg |
|---|---|
| Hoeveelheid | 10 tabletten, 30 tabletten, 60 tabletten, 90 tabletten, 180 tabletten |
Vragen & antwoorden
Gerelateerde producten
Beoordelingen
Er zijn nog geen beoordelingen